Home / Inspections / 1028754

FDA Inspection 1028754 — Implant Direct Sybron International, LLC

Implant Direct Sybron International, LLC — FEI 3009036368

The FDA completed an inspection of Implant Direct Sybron International, LLC on September 26, 2017 in Las Vegas, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 26, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Las Vegas, NV (United States)

Facility

Other inspections at this facility

  • 988719 (NAI Mon Aug 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 982340 (NAI Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 891481 (NAI Thu Aug 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources